Email : info@nexusalliancebiopharma.com
Contact : (321) 445-1969

Immunotherapy and target therapy in non-Hodgkin's lymphoma

Abstract

Non-Hodgkins's lymphomas (NHL) are a heterogenous group of B and T cell malignancies primarily involving lymphatic system. NHL is fifth leading cause of cancer mortality. Due to evolving science and better understanding of pathophysiology of the disease leading to the subsequent development of newer targeted agents, the potentially curable variants of NHL are increasing. In this paper, we will discuss the current trends in utilizing immunotherapy to fight NHL along with the different molecules involved in the proliferation of the disease..

Download Pdf